Skip navigation
Skip navigation

Early cognitive deficits in Swedish gene carriers of Huntington's disease.

Robins-Wahlin, T.B; Lundin, Anders; Dear, Keith

Description

The primary focus of this study was to examine whether there is early neuropsychological impairment in presymptomatic Huntington's disease (HD). A broad neuropsychological assessment battery was administered to 24 asymptomatic gene carriers (HD+) and 31 noncarriers (HD-). The gene carriers revealed inferior cognitive functioning as compared with the noncarriers in memory and executive functions. When the gene carriers were assigned to 2 groups based on predicted years to onset (with 15 and over...[Show more]

dc.contributor.authorRobins-Wahlin, T.B
dc.contributor.authorLundin, Anders
dc.contributor.authorDear, Keith
dc.date.accessioned2015-12-08T22:19:57Z
dc.identifier.issn0894-4105
dc.identifier.urihttp://hdl.handle.net/1885/31784
dc.description.abstractThe primary focus of this study was to examine whether there is early neuropsychological impairment in presymptomatic Huntington's disease (HD). A broad neuropsychological assessment battery was administered to 24 asymptomatic gene carriers (HD+) and 31 noncarriers (HD-). The gene carriers revealed inferior cognitive functioning as compared with the noncarriers in memory and executive functions. When the gene carriers were assigned to 2 groups based on predicted years to onset (with 15 and over being HD+ late and under 15 being HD+ near), the HD+ near group performed significantly worse than the HD+ late group in all domains but ability to shift conceptually and visuospatial memory. Results suggest that early cognitive deficits are detectable prior to motor symptoms, first in memory functions and then in executive functions and perceptual motor speed.
dc.publisherAmerican Psychological Association
dc.sourceNeuropsychology
dc.subjectKeywords: antiasthmatic agent; antidepressant agent; benzodiazepine derivative; diuretic agent; neuroleptic agent; adult; article; asthma; cognitive defect; concept formation; controlled study; early diagnosis; female; heart disease; heterozygote; human; Huntington Cognition; Cognitive deficits; Executive functions; Gene carriers; Huntington's disease; memory; Presymptomatic
dc.titleEarly cognitive deficits in Swedish gene carriers of Huntington's disease.
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume21
dc.date.issued2007
local.identifier.absfor111706 - Epidemiology
local.identifier.ariespublicationu3962038xPUB86
local.type.statusPublished Version
local.contributor.affiliationRobins-Wahlin, T.B, Karolinska Institute
local.contributor.affiliationLundin, Anders, Danderyd's Hospital
local.contributor.affiliationDear, Keith, College of Medicine, Biology and Environment, ANU
local.description.embargo2037-12-31
local.bibliographicCitation.issue1
local.bibliographicCitation.startpage31
local.bibliographicCitation.lastpage44
local.identifier.doi10.1037/0894-4105.21.1.31
dc.date.updated2015-12-08T08:26:49Z
local.identifier.scopusID2-s2.0-33846087451
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_Robins-Wahlin_Early_cognitive_deficits_in_2007.pdf1.2 MBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator